One possible mechanism to explain the worsening of heart failure in patients taking DPP-4 inhibitors is sympathetic overactivity through potentiation of endogenous stromal cell-derived factor 1, neuropeptide Y, and substance P [58]. Here, DPP4 is linked to heart failure.